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¯ Abstract:
Hearing loss can occur in a variety of ways, and in every
case, they have equally devasting effects. While hearing loss
and the people who suffer from it shall not be discriminated
against, attempting to offer options for treatments nevertheless
should be of priority. As such, there has been much progress in
the field of genetically based forms of treatment for
sensorineural hearing loss. A gene that has been almost always
implicated in the conversation of regeneration, Hair Cell and
Spiral Ganglia development, and inner ear development, in
general, is the Zing Finger transcription factorsGata3.
Furthermore, since the Organ of Corti is a complex organization
of cells, we found a perfect opportunity to document the effect
of Gata3 in cells of the GER that do not usually express high
levels of Gata3. Thus, we were interested in documenting the
effects of Gata3 overexpression on the genetic profile of these
cells. To do this we decided to overexpress gata3 in the cells of
the GER. We utilized the tamoxifen-inducible Cre recombinase
transgenic mouse line Fgf10-CreERT2 to characterize Ffg10
expression in the GER (Fgf10-CreERT2:tdTomato), to then have
certainty in our method of inducing overexpression of Gata3
(Fgf10-CreERT2:Gata3OE) in the cells of the GER. In doing this,
we found no significant evidence that Gata3 overexpression
causes any drastic morphologic or cell fate changes in the OC.
This grants us some confidence. That if Gata3 ever be used as
a treatment option in the future; for either sensorineural hearing
loss treatment, HDR (Gata3 haploinsufficiency), or preemptive
protection against expected otic trauma, it should not create any
abnormal changes in the OC.

¯ Introduction:
•

Hearing loss and the layout.

Sound perception is for many people, an extremely
intricate piece of a subject’s experience of the world around
them. Hearing is associated with the pinnae, the ear canal, and
the eardrum as a regular visit to the ear, nose, and throat doctor
might have already revealed; however, the full story behind

hearing is far more complex than any little look in the mirror
should reveal. Loss of hearing, of any kind, is an extremely
common affliction in the world, however, due to the complexity
and the variety of different ways hearing loss can occur, in
combination with the familiarity bred ignorance we have over
this sense, hearing loss and hearing disorders have long been
overlooked. In the United States, 15% of the population over
eighteen years of age indicate some form of hearing
impairment, while 13% percent of the population indicates
hearing loss in both ears (Lin et al., 2011; Blackwell & Lucas,
2012). Sources of hearing loss include congenital hearing loss,
which is a result of a genetic disorder, ototoxic drugs, often due
to the overuse of antibiotics or use of chemotherapeutic drugs,
such as cisplatin, noise-induced trauma, and age-related hearing
loss (Prell et al., 2019; Hodge et al., 2021). As a result of the
multitude of ways one can lose their hearing, treatment option
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development has been slow, and insufficient in many cases.
Apparatuses, such as hearing aids and cochlear implants are
some of the most recognizable. Reasons for the inefficiency of
these methods can range from the necessity of the presence of
the same sensory cells which are already damaged, or because
they are simply unpleasant to wear and use.
Sound transduction is a multifaced process, with various
checkpoints which allow for a variety of complications to
occur. Hearing begins once sound waves are funneled into,
essentially captured, by the auricle. The ear canal then allows
the sound waves to travel and vibrate the tympanic membrane.
Once the tympanic membrane is struck, it causes the vibration
of the attached ossicles (from malleus to incus, to stapes), in the
middle ear, which faithfully vibrates at the frequency of the
sound waves that entered the ear canal. Transduction continues
once these sound waves are transduced from the ossicles to the
inner ear, by vibrating the oval window, which touches the
sound transducing organ, the cochlea.
The inner ear and its labyrinth anatomy consist of six
sensory organs that should be familiar to anyone investigating
the functional anatomy of the organ. The detection of gravity,
balance, linear and angular acceleration, and of course, sound,
rely on the relationships between populations of ectodermderived cells that interact within the inner ear. There are six
organs responsible for the perception of the five senses stated
above and are distributed amongst two sensory domains,
cochlear and vestibular. The first three vestibular organs are the
three semicircular canals and their respective cristae organized
in an orthogonal axis to each other, allowing for the perception
of angular acceleration and balance. Next, are the other two
vestibular organs responsible for the perception of gravity and
linear acceleration, the saccule, and utricle. Finally, the cochlea
exerts its role as the complex organ responsible for auditory
function.
The cochlea is composed of three major delineated spaces:
the Scala vestibuli, Scala tympani, and the cochlear duct. The
oval window, once vibrated, moves the fluid termed perilymph
in the Scala vestibuli back and forth, maintaining the initial
frequency. This fluid is then able to vibrate a crucial structure
of the cochlear duct called the basilar membrane. This structure
is of great importance because it is able to selectively vibrate in
response to different frequencies, which is termed mechanical
tunning. This then creates a frequency gradient along the length
of the cochlea. Higher frequencies, perceived as higher pitch,
travel the smallest distance, due to the impedance of the fluid in
the cochlea, and the basilar membrane vibrates to these
frequencies at the basal region (closest to the oval window).
Lower frequencies, perceived as lower pitch,
have longer wavelengths that travel further, and as such the
basilar mirbane vibrates with selectivity to these frequencies in
the apex of the cochlea. This allows for the concept of a spatialfrequency colocalization along the length of the cochlea, which
allows for selective sensorineural transduction towards the
central nervous system (CNS), otherwise known as the
tonotopic map.
The perception of sound is attributed to the function of two
crucial sensory cell populations, hair cells (HC) and spiral
ganglion neurons (SGN). Within the cochlear duct (CD)
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between the greater epithelial ridge (GER) and the lesser
epithelial ridge (LER), we can find a patch of tissue where the
mechanosensory cells are found (Fig. 1) (Ohyama et al., 2010).
The organ of Corti (OC), is home to several types of specific
cells, which house two main populations: supporting cells (SC)
and HCs (Kelly et al., 2009, Groves and Fekete 2012). The OC
is the specialized epithelia in the CD and contains three rows of
outer hair cells (OHC) and one row of inner hair cells (IHC)
(Fig. 1) (Dabdoub et al., 2008; Basch et al., 2016). The IHCs
are the cells that get directly stimulated by the moving fluid in
the CD caused by the vibrating tectorial membrane, which is
connected to the basilar membrane. On the other hand, OHCs
offer a modulatory and tunning function by contracting and
increasing IHC stimulation or protecting the same from
excessively loud sounds (Puligilla et al ., 2010).
This population is followed by its opposing neuronal
population, which innervates and allows for the final step in
auditory transduction for central processing. The specific
pattern of innervation in the OC is of utmost importance. The
IHCs and OHCs respectively have their own specific
innervating populations of SGNs. The two main types of SGNs
are: Type I SGNs, which account for 95% of SGNs, and Type
II SGNs, which account for 5% of SGNs (Benoudiba et al.,
2013; Nishimura et al., 2016). Extending SGNs obey the border
exertion set by the OC and the two nonsensory regions. Type I
SGNs solely innervate IHCs along the more medial region of
the OC, presenting multiple points of synapsing on these cells.
Type IIs, on the other hand, innervate OHCs and extend past
the tunnel of Corti, making a right “base oriented” turn to
innervate and synapse with multiple OHCs along the three rows
(Fig. 1). The multiple synapsing abilities of Type II SGNs
further their role as a modulatory pathway for sound perception,
and “loudness” (Fritzsch et al ., 2010; Weisz et al., 2009). The
SGNs innervate the cochlea (Liu et al., 2000; Ma et al., 1998),
and along with the vestibular neurons, will coalesce into the
VIIIth cranial nerve, which then extends to the hindbrain
(Bouchard et al., 2012). Upon reaching the hindbrain, the
vestibular afferents project to the vestibular nucleus in the
hindbrain, while cochlear afferents project towards the cochlear
nucleus. Within the cochlear nucleus, the tonotopic
organization, base to apex pattern, is preserved in multiple
subdivisions, which offers our perception of frequency
discrimination (Pickels 2015; Koundakjian et al., 2007). These
physiological variations between HCs and SGNs, their
organization, and the particular molecular interactions they
have, are the microscopic tools that enable the auditory abilities
of the inner ear.

•

Early otic development and crucial genes and
signaling cascades.

FGF signaling in general can work one of two ways, it can
operate through the general receptor tyrosine kinase (RTK), or
through the JAK-STAT pathway. FGF10, which is part of the
keratinocyte growth factor superfamily or the FGF7
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superfamily, all function through the RTK pathway. The RTK
pathway functions primarily by allowing dimerization of two
tyrosine-containing transmembrane proteins that will lead to
phosphorylation of GAP proteins, which then proceed to
activate the Ras G protein, which through binding to GTP
allows for activation of proceeding downstream messengers.
These second messengers eventually reach transcription factors
within the nucleus that upon phosphorylation allow for the
transcription of many target genes.
Inner ear development begins like every other sensory
organ. Morphogen gradients that are generated in early
gastrulation determine pre-placodal regions along the ectoderm,
thus leading to specification of future sensory organs. After this
pre-placodal sensory competent tissue had become committed
to developing into its respective sensory tissue, specific genetic
profiles begin to be expressed. In the case of the inner ear, many
signaling pathways have been identified as being crucial for its
initial development, and two target genes, Fgf10 and Gata3, are
expressed early on and continue to have an effect throughout
development at different stages. One of the earliest signals of
otic placode development are the precursor genes, Fgf3 and
Fgf10 as they are expressed in the otic placode, just preceding
otic invagination around E 7.5 (Wright & Mansour, 2003).
Analysis of FGF signaling is difficult primarily due to the
redundancy mentioned above. Fgf2, while it known to induce
primordial otic fate genes, such as Pax2, is however not capable
of promoting complete otic development, which demonstrated
that a combination of FGFs signaling in a time-specific fashion
is necessary (Martin & Groves 2006). As such, it has been
postulated that the observed early Fgf3 and Fgf10 are possible
inducers of the otic invagination process, as individual
knockout of both of these yields’ faulty otic development
(Ohyama et al., 2007). FGF signaling is also heavily involved
in the axiation process of the otic cup and signaling arrives from
the hindbrain region adjacent to the developing Stato Acoustic
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Ganglion (SAG) in chicks
(Schneider-Maunoury
&
Pujades, 2007).
Another crucial gene
and one that could possibly
be involved in the cascade of
FGF signaling in the preplacodal
and
cranial
placodes is Gata3. The zinc
finger domain transcription
factor GATA3 is encoded by
the Gata3 gene, and for its
purposes in the inner ear, its
splicing pattern seems to be
hinging on the fifth exon
cleaved from the pre-mRNA.
Gata3 is expressed in a
variety of tissues, however, it
is very well known for its
effects in renal development
and
immune
cell
differentiation, however it is
also crucially involved in
otic development. Gata3
expression is observed early on in otic development and is
visible throughout the otic vesicle after invagination in the
earliest time points such as E8.5 and E9.5 (Luo et al., 2013). It
has been previously shown, in accordance with this heavy
expression, that Gata3 is crucial for the proper development of
the inner ear, and at different times it performs different
functions throughout otic development. Gata3, along with
Sox2, is one of the earliest sensory epithelia specifying genes,
and they are both present at the earliest stages of invagination.
While Sox2 seems to have, a role in early stages of proliferative,
Gata3 is not so simple. From an early stage, Gata3 has patterns
of expression that appear to prime future sensory epithelia
regions and has restricted expression just two days after
invagination E10.5 (Karis et al., 2001).
The general trend that is observed in the earlier days of
otocyst invagination and general domain specification is mainly
spatiotemporal. Probably because of the severe redundancy that
FGF signaling has in early development, and the incredible
number of genes that are controlled by GATA3 it is hard to pin
what is the specific connection between these two, most likely
because there is not just one. Because of this parallel
expression, the relationship between Gata3 and Fgf10, and their
respective phenotypes in null models have revealed extensive
thinking as to why look further into this relationship at later and
more specific stages.

•

FGF10 and GATA3 role in Sensory epithelia and
organ of Corti development.

A crucial characteristic of FGF signaling in the OC is in its
specification of sensory and nonsensory cells in the prosensory
region, a precursor area of competency for OC development.
Specifically, FGF signaling is heavily involved in OC
patterning by being presented in gradients. Fgf20 is seen to be
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expressed in very high levels most specifically in the putative
prosensory epithelia around E12 day of otic development, just
after Sox2 expression and development and proliferation of the
sensory precursor cells (Martin & Groves 2006; Kiernan et al.,
2005; Munnamalai & Fekete 2016) (Fig. 2). Furthermore,
Fgf10 is also involved in specifying two crucial regions of the
OC and the morphology of the cochlear duct as well. Fgf10 is
known to influence Bmp4 expression in the LER, as its
expression is seen to be necessary for the specification of the
Bmp4 competent region (Ohyama et al., 2010; Urness et al.,
2015). Fgf10 is also necessary for the development of the
Reisner’s membrane and the general morphology of the
vestibular system (Urness et al., 2015). However, in the
cochlea, its strongest expression profile is apparent in the GER,
in opposition to the OC on the neural side, where it remains
until postnatal days.
Gata3 is one of the primary genes seen to be expressed
in the OC, and the neuronal progenitor of the pre-delaminated
cochlear vestibular ganglion (CVG) (Karis et al., 2001;
Lawoko-Keralli et al., 2003) (Fig. 3). However, its role in OC
function is most crucially seen in its apparent role in
determining where sensory epithelia will develop. GATA3
staining demonstrates that its protein is most strongly seen from
E12 until E14 to be restricted to the prosensory and future OC
region, which is the period when the HC and SC progenitor
populations are begin specified, identified by SOX2,
EYA1/SIX1 expression in the same region (Luo et al., 2013,
Kiernan et al., 2005, Ahmed et al., 2011). Aside from this
apparent role in progenitor delineation, Gata3 also appears to
be a regulator of HC differentiation and monitoring which cells
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can become HCs and will mature into functional ones.
There has been a significant investigation in the very
tight regulation and specification between IHCs,
phalangeal cells, pillar cells, and GER border cells, all
of which elucidate the complexity of border
specification. Specifically, it has been shown how this
is regulated by Hes/Hey factors being active or not, of
which themselves are regulated by Gata3, which has
generated suspicion of this being a direct role of this
gene (Basch et al., 2015; Luo et al., 2013).
In two studies, which eliminated Gata3 at two
different times, it was observed that by deleting Gata3
at E8, during initial inner ear development, its deletion
had great morphologic effects which either directly or
by proxy caused the absence of any sensory tissue in
the cochlea. The cochlea was severely atrophied and
demonstrated little to no development at all, and
logically, there was also no present sensory epithelia
(Duncan et al., 2011). Deleting Gata3 just a day later
at E9.5, after some sensory specification has already
taken place, Gata3 conditional knockouts (CKO) also
demonstrated severe morphological defects, however,
these were less prominent than the earlier null mutants.
Most specifically, however, there was a very sparse
development of sensory epithelia and some HCs. The
OC presented almost no organization, HCs were few,
and also has significant development malfunctions,
primarily observed by maldeveloped stereocilia.
The role of FGF signaling and most
specifically of Fgf10 expression in the inner ear has been in
large part due to the data collected from null models. One null
model, which eliminated Fgf10 prior to any otic development
shows a number of developmental problems. Most notable, is
the presumable role FGF signaling has on the morphologic
development of the vestibular system, as Fgf10-/- mice
demonstrated complete loss of the posterior semicircular canal,
as well as the atrophied cochlea. Furthermore, OC development
demonstrated great defects as well. Null Fgf10 models
demonstrated a dose-dependence since Fgf10+/- mice
demonstrated graded effects, such as the loss of a proper
Reissner’s membrane, shortened cochlear ducts, and small OC.
However, there was the presence of HCs (Urness et al., 2015).
It is interesting to note that Fgf10 has a transient expression
around the OC, as it begins to be expressed in the LER,
supposedly priming future BMP4, and then progresses
counterclockwise through Reisner’s membrane and finally to
the GER where it ends in the GER (Urness et al., 2015; Groves
and Fekete, 2012). Thus, Fgf10 seems to have a great
morphologic impact by specifying nonsensory regions of the
OC, which ultimately leads to interest in what is its role within
nonsensory cells of the OC that are just adjacent to the OC,
where Gata3 is presently active, also taking into consideration
that Gata3 regulates Fgf10 (Luo et al., 2013; Lilleväli et al.,
2007).
The interaction of Gata3 and Fgf10 in the
development of the sensory epithelia and neurons in the inner
ear has been long suspected. Studies have shown that Gata3
does indeed directly regulate Fgf10 levels of mRNA expression
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• The interest of investigation and plan of
approach.

through in-situ hybridization and through qPCR analysis (Luo
et al., 2013; Duncan et al., 2013). Notably, there is a specific
effect on the nonsensory cells of the OC, both the GER and the
LER cells, since Gata3 knockdown also provokes a decrease in
the Bmp4 expression levels (Fig. 4). Furthermore, this
interaction is made more interesting because Gata3 and FGF
signaling has been shown to be crucially involved in the
specification of IHCs and the cells of the GER. It is not known
what the actual mechanism for the border specification is.
However, Gata3 is crucially involved since it has a direct effect
on GER-specific genes, such as Fgf10, and on OC genes for
lateral inhibition, such as Jag1 and Hes/Hey factors (Basch et
al., 2016; Luo et al., 2013). Furthermore, Gata3 has been shown
to be necessary to keep cells from entering stages of HC
development by controlling the expression of the mitotic factor
gene p27Kip1, which is thought to be necessary for determining
what cells become in the OC (Walters et al., 2017).
Finally, the interplay between Gata3 and Fgf10 is also
shown to be actively present within neurons. The same
regulation of Gata3 over Fgf10 expression has been observed
in neurons in the CVG, with Gata3 known leading once more
to a concomitant decrease in FGf10 expression (Lilleväli et al.,
2007). While a direct regulation of the gene of the ligand is
evidence enough, Gata3 knockdown also demonstrates a
downregulation in one of the two main targets for such ligand,
FGFR1b, which could serve as a possible explanation for why
neuronal pathfinding and HC synaptogenesis is erroneous in
Gata3 knockdown (Appler et al., 2013).

With these relationships in mind, it is why the
tamoxifen-inducible Fgf10-creERT2: Gata3OE line
is of such interest. Although much of the
developmental cues and interaction between
these two genes, this study was nonetheless
interested in investigating the effect that Gata3
would have on postnatal time points. In adult
time points, the OC and all of its cell types have
been specified, differentiated, and matured.
However, Gata3 was still shown that in late
embryonic time points and early postnatal time
points if manipulated could allow for the
presence of ectopic HC courses (Walters et al.,
2017). Thus, given the various roles of Gata3
and its influence on the crucial, equally
multitasking, Fgf10 gene, we set out to
investigate this interplay. Our line utilizes CreLoxP technology to enable overexpression of
Gata3 in a cell-specific and time-specific
manner. We first set out to characterize Fgf10creERT2 expression in the mature cochlea, using
the Fgf10-creERT2: tdTomato line, with an
injection of pups at P14 with tamoxifen (6 mg /
40 kg). This allowed us to localize and
characterize where we would overexpress
Gata3 within the over-expresser model and
determine the effects of Gata3 overexpression in the tissues that
correspondingly we identified with tdTomato recombination.
We would like to know if the relationships outlined throughout
embryonic development, and overexpression of Gata3 would
have any drastic effects on an adult and differentiated OC.

¯ Methods:
•

Transgenic Mouse lines.

The Fgf10-creERT2 mouse line was gifted to the Duncan lab by
Dr. Bellusci (Agha et al., 2021). This mouse line was
characterized using the following primers: forward
(ATTTGCCTGCATTACCGGTC),
reverse
(ATCAACGTTTTGTTTTCGGA). The Rosa26 locus TdTomato
transgene mouse room was acquired from Jackson Laboratory.
The following were used for identification: forward
(AAGGGAGCTGCAGTGGAGTA)
and
reverse
(CCGAAAATCTGTGGGAAGTC). The Gata3OE mouse line was
gifted to the Duncan lab by Dr. Bouchard (Nguyen et al., 2013).
The
following
primers
were
used:
forward
(AAAGTCGCTCTGAGTTGTTAT),
reverse
Mutant
(GCGAAGAGTTTGTCCTCAACC),
and
reverse
WT
(GGAGCGGGAGAAATGGATATG).
•

Mouse Collections and Preparations.
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Mice were injected with 6 mg per 40 kg tamoxifen (Sigma, cat.
T5648) pup body weight to induce the modified estrogen
reception on the Cre-recombinase protein at P14. Pups were
then collected at P21 by euthanization using a lethal 500 mg/kg
dose of Avertin (2,2,2- tribromoethanol; Sigma cat. T48402).
Pups were fixed using 4% paraformaldehyde (PFA) via
transcardial perfusion using a peristaltic pump. All animal
breeding and euthanasia were conducted following the
procedures approved by Western Michigan University’s
Institutional Animal Care and Usage Committee (IACUC) #2101-11. Before completing animal studies, researchers
concluded the Collaborative Institutional Training Initiative
(CITI) for animal research.

removed from the primary antibody solution and rinsed with
one rapid exchange of 0.05% Tween20/PBS. Then, four washes
of 30 minutes of the same 0.05% Tween20/PBS were carried
out on a rocking plate. Following this, secondary antibody
solutions were added in equal amounts to each ear. All
secondary antibody solutions were spun in a centrifuge for 10
minutes at 14000 rpm before addition into wells containing
ears. Samples were then incubated at 4˚C on a rotating platform
overnight. Following second incubation, samples were washed
for 30 minutes three times with PBS. Following washes,
samples were transferred onto glass slides arranged with hair
cells facing upwards, and coverslips were added after samples
were immersed in glycerol.

•

•

Immunohistochemistry

Pups were dissected in PBS under a microscope, and the
cochlea was then placed into a 96-well plate, where the
cochleae remained in PBS for upwards of 1 hour. After
removal, ears were prepared by being washed with 0.05%
Tween20/PBS 5 times with each wash consisting of 5 minutes
on a rocker. Ears were then blocked for 30 minutes on a rocker
in a blocking solution, composed of 2.5 (5%) mL of donkey
solution, 47.5 mL of PBS, 0.5 g of Bovine Serum (BSA), and
50 µL of TritonX-100. The ears were then washed with several
exchanges of 0.05% Tween20/PBS. Ears were then placed into
a combination of diluted primary antibody solutions. For Fgf10creERT2: tdTomato as well as Fgf10-creERT2: Gata3OE samples the
following primary antibodies were added; Rabbit MyoVIIa
(Proteus Biosciences) were diluted in Blocking solution 1:500,
Chick NF200 (Aves©) diluted in Blocking solution 1:200,
DAPI (Hoechst dye) diluted 1:2000, and Phalloidin 488 diluted
1:1000 in blocking solution all were added to individual ears,
and Phalloidin 488 diluted 1:1000 in blocking solution. Ears
were then incubated for at least two days at 4˚C on a rotating
platform. Following the incubation, period ears were then

Imaging and image editing.

Samples were taken on a C2 Nikon confocal that had previously
undergone immunohistochemistry. Images were analyzed, and
Z stacks were compiled using the Fiji-ImageJ editing software.
Images were finalized and edited for observation using Corel
Draw; the images generated here are seen in the results sections.
All images are representative of – replicates.

¯ Results:
•

Characterization of the Fgf10-creERT2: tdTomato.

Prior to overexpressing Gata3, we had to assure ourselves
that the Fgf10-creERT2 method of transgenic engineering would
confidently work in overexpressing Gata3 in the nonsensory
cells of the GER. For this, we utilized the tamoxifen-inducible
(ERT2) Cre-recombinase protein. By knowing that Crerecombinase would only be expressed under the Fgf10
promoter. Under normal conditions, it would not be
translocated to the nucleus. Upon activation by tamoxifen,
which binds to the modified estrogen receptor on the Cre-
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Recombinase protein, allowing for it to carry out genetic
recombination. At the Rosa26 locus, a stop codon would be
removed, allowing for the expression of the endogenous
fluorescence of tdTomato which the mice possessed (Fig. 5).
After injection of the mice at P14, we collected mice at
P21, where we prepared the samples for analysis. We observed
sufficient recombination carried out by cre-Recombinase in the
GER all along the length of the cochlea (Figure 6, white
brackets). The border cells are specifically the most significant
stained, and a decreasing gradient through the GER. Due to the
observed fluorescence, we felt confident that utilizing the
Fgf10-creERT2 mouse line would allow for overexpression of
Gata3, only in the GER.
Fgf10-crERT2: Gata3OE provokes no observable change
in OC organization, morphology, or cells types.

indeed

A

I

I

V

O

Y

M

A

I

I

V

O

M

A

I

I

V

O

Y

M

We set out to, by the same mechanism of inducible Cre
lines, overexpress Gata3 in the GER. Upon overexpression, no

Y

•

observable phenotypes can be seen. HCs can be seen as being
stained red, and in all three figures, control, heterozygous and
homozygous, the HC rows (one IHC and three OHC) can be
seen as present. Gata3 overexpression at this stage also does not
cause any IHC duplets, as previous data has shown to be the
case in embryonic timepoints. Furthermore, overexpression of
Gata3 does lead to any drastic morphological phenotypes, as
seen to be the case in Gata3 null models. While null models
dealt with the loss of Gata3, its role as a border maintainer gene,
especially with its interactions with Fgf10 was reason to believe
overexpression could cause some morphologic, or border
phenotypes (Fig 6). It is interesting to note that at this age it
seems like this dynamic interaction at the border has reached a
point of stagnation and seems solidified. Phalloidin reveals that
the pillar cells, seen in between both HC rows, maintain the
proper organization as well, and taken with the observed
conserved order of the OC, it seems reasonable to postulate that
Gata3 overexpression does not have a significant role in border
exertion, the morphology of OC, or HC fates in GER cells.
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¯ Conclusion:
Most of the knowledge discussed previously has all been
carried out in embryonic time points, with its focus to address
the questions of congenital hearing loss, whereas postnatal
studies typically focus on applying their findings to other forms
of hearing loss, although not restricted to such.
It has been shown that congenital deficiencies in Gata3
lead to misexpression of Fgf10, thus causing large-scale
morphology problems in inner ear development. Focusing
mainly on the border of the GER and the OC, Gata3’s involved
here, and subsequentially its influence over Fgf10 is crucial to
establish which cells become HCs and which cells become
nonsensory. Clearly, there is an intriguing mechanism at play
here (Basch et al., 2016). It has been shown and hypothesized
by many that these cells, phalangeal cells, pillar cells, GER
cells, and IHCs have a very specific way of acquiring this fate,
and given that GATA3 is seen in high levels in HCs at these
stages, it is not impossible to imagine that its expression pattern
here is crucial for the specification of which cells become
which. Previous studies have demonstrated that
transdifferentiating of HCs can occur by manipulating crosstalk
between GER cells, IHCs, and inner pillar cells (McGovern et
al., 2019); however, no studies have shown such a relationship
this late in embryonic time points. At postnatal stages, the OC
has mainly been considered static in terms of cell fate after
some studies have pointed out that early in the postnatal days,
and late embryonic days, Gata3 seems to still play a role in the
quiescence of supporting cells and GER by regulating mitotic
factors p27Kip1, and that if Gata3 levels are reduced, along with
loss of HCs, ectopic HCs can be identified (Xu et al., 2021,
Walters et al., 2017).
Many different forms of hearing loss can occur, but they
seem to target HCs, specifically noise-induced, ototoxicity, and
age-related hearing loss can happen in a multitude of ways.
However, typically the end result is the loss HCs or SGNs. Loss
of Gata3 has also been linked with deafness, primarily through
HDR
syndrome.
HDR
syndrome
involves
the
haploinsufficiency of Gata3. The subsequent loss of one or
more alleles of Gata3 can cause congenital renal disease,
sensorineural hearing loss, and hypoparathyroidism. As such
Gata3 has been linked with congenital hearing loss. Given the
background of HCs, their differentiation, and the role of Gata3
on border exertion, it has been postulated that Gata3
overexpression could provide some help in HC regeneration, or
at least protection. Gata3, along with other transcription factors
has been demonstrated to allow for the expression of HC
differentiation marker Pou4f3, which has led to much
excitement over Gata3 as being a new path for possible genetic
therapies (Masuda et al., 2012). However, when it comes to
rescuing HCs, the result has not been so promising. HCs show
some form of regeneration in the vestibular system (Burns &
Stone 2016), where Gata3 expression seems alike in regulating
HC differentiation however in the cochlea, HCs have presented
any identification of a possible regenerative function.
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However, Gata3 nonetheless has been strongly linked to
maintaining HCs, particularly for the data surrounding its role
in upregulating Pou4f3 in GER cells, and loss of Gata3 has
shown decreases in HC gene Atoh1 and a decrease in HC
critical Transcription factor Eya1 (Duncan et al., 2013; Masuda
et al., 2013). As such, the role of Gata3 has been more strongly
linked to being one of HC fate maintenance, rather than
initiating the developmental cascade, possibly improving key
transcription factors and regulatory site interactions. For this
reason, many therapy options have surrounding possibly
granting “extra copies” of Gata3 as possible protection for
expected HC trauma or for HDR syndrome patients. However,
there is worry about utilizing Gata3 as such because its
regulatory functions are not entirely known, specifically
surrounding HC fates, OC morphology, and cochlear duct
morphology. And reluctance may be held in not knowing if
Gata3 requires a sort of homeostatic level for popper OC
function, or if at this stage, only loss of Gata3 can affect
hearing.
Our study answers this question by knowing that at least
overexpression of Gata3 at this stage does cause any adverse
reaction. Morphologically speaking, and most predictable the
cochlea seems normal, as expected. Next, there were no
observable ectopic hair cells in the GER or the OC. This is
interesting because Gata3 was one of the transcription factors
needed for strong Pou4f3 upregulation in the GER cells, hover
it seems that at this stage, the GER cells have been specified
sufficiently that they maintain the original epithelial fate.
Finally, the OC and its border with the GER seems unaffected
as well. It would however still be necessary to investigate what
would happen if Gata3 were to be lost abruptly, at this stage in
life, the early postnatal days, if this would have any effects. It
is also necessary to investigate and quantify through qPCR if
the Gata3 transcripts in the GER were elevated, since the
possibility of these cells simply not even expressing the extra
copies of Gata3 also exists.
However, our data is reassuring as it allows us to know that
“too much” Gata3 is not a concern with perfectly healthy OCs.
Thus, many treatments options that have been supposing
transgenic methods of treating or alleviating hearing loss do not
have to worry about it affecting the morphology, cell fate, or
interfering with the extremely specific cell organization in the
OC. Methods such as AAV injection could be used to supply
patients with extra copies of Gata3 if necessary, and our data
would suggest that if this dose is given to an already normal
level of Gata3, targeting cells of the GER at least, the OC
should remain the same, while Gata3 could offer its protective
functions.
Taking all of this into account, this study demonstrates
evidence that overexpression of Gata3 through Fgf10-creERT2
recombination does not cause any aberrant or observable
phenotypes, however more quantitative approaches are still
necessary, as well as more investigation into the role of Gata3,
both embryonically as well as postnatally if it ever were to be
considered as a possible avenue for hearing loss or hearing
disorder therapy.
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